Loestrin Fe 1/20
NDC Package 51285-080-70

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Loestrin Fe 1/20 is a . Marketed by Teva Women's Health, Inc., this product is identified by NDC 51285-080 and is authorized under FDA application ANDA076081.

Identification & Billing

NDC Package Code
51285-080-70
Package Description
5 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK
Product Code
51285-080
11-Digit Billing Format
51285008070
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
5 EA

Clinical Specifications

Proprietary Name
Loestrin Fe 1/20 28 Day
Dosage Form
-

Regulatory & Marketing

Labeler Name
Teva Women's Health, Inc.
FDA Application #
ANDA076081
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-01-2008
End Marketing Date
11-30-2015
Listing Expiration
11-30-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51285-080-70 identifies a specific commercial package of 5 pouch in 1 carton / 1 blister pack in 1 pouch / 1 kit in 1 blister pack of Loestrin Fe 1/20 28 Day, labeled by Teva Women's Health, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Women's Health, Inc. on October 01, 2008. The current certification is valid through November 30, 2015.

How is this Teva Women's Health, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51285008070. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51285-080-70
11-Digit CMS (5-4-2)
51285-0080-70

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.